CHAM, Switzerland, Aug. 12 -- CNS Drugs, a journal that says it provides researchers and healthcare professionals with information on the aspects of drug therapies used for the management of neurological and psychiatric disorders, published research articles on the following topics in its September 2024 edition (Vol. 38, Issue 9):

* Psychotropic Drugs Reemerging as Headache Medicines

* When, Why and How to Re-challenge Clozapine in Schizophrenia Following Myocarditis